Riudavets M, Naigeon M, Texier M, Dorta M, et al. Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial. Lung Cancer 2021 Dec 3. pii: S0169-5002(21)00624.
PMID: 34953624